SCHEMBL21496347

SCHEMBL21496347

C[C@H](C(=O)Nc1ccc(F)cc1)C12CC(NC(=O)c3cc4ccccc4cn3)(C1)C2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 14/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ CSF1R P07333 1/20 0.40
▸ RET P07949 1/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ PDGFRA P16234 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ HDAC3 O15379 2/20 0.39
▸ HDAC1 Q13547 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21504298 1.00 IDO1 (0.67) IDO1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL24118309 0.84 IDO1 (0.74) IDO1SMN1; SMN2MAPTNPC1ALDH1A1
SCHEMBL30055468 0.84 IDO1 (0.74) IDO1SMN1; SMN2MAPTNPC1ALDH1A1
SCHEMBL21496351 0.83 IDO1 (0.76) IDO1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL21496353 0.83 IDO1 (0.76) IDO1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL24118368 0.82 IDO1 (0.63) IDO1SMN1; SMN2NPC1ALDH1A1GAA
SCHEMBL30055209 0.82 IDO1 (0.63) IDO1SMN1; SMN2NPC1ALDH1A1GAA
SCHEMBL24118289 0.82 IDO1 (0.72) IDO1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL30057681 0.82 IDO1 (0.72) IDO1SMN1; SMN2LMNAMAPTNPC1
SCHEMBL21496414 0.81 IDO1 (0.69) IDO1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781142-A1 NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS Merck Sharp&Dohme Corp. (US) 2021-02-24 — — EP claimed
WO-2019204180-A1 NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2019-10-24 — — WO claimed
Send feedback